Researchers
Gagić, Žarko
Type
Date issued
Results 1-15 of 15
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2025 | Challenges in the preclinical design and assessment of CAR-T cells | Tomai, Radu; De Las Rivas, Javier; Fetica, Bogdan; Bergantim, Rui; Filipić, Brankica   ; Gagić, Žarko ; Nikolić, Katarina ; Gulei, Diana; Kegyes, David; Nistor, Madalina;
Ximena Maria, Muresan; Cenariu, Diana; Feder, Richard; Pavel-Tanasa, Mariana; Cianga, Andrei; Tigu, Adrian Bogdan; Munteanu, Raluca; Tanase, Alina; Einsele, Hermann; Tomuleasa, Ciprian;
| Article | 21M21 |
| 2025 | Green Extraction Combined with Chemometric Approach: Profiling Phytochemicals and Antioxidant Properties of Ten Species of the Lamiaceae Family | Teofilovic, Branislava ; Gligoric, Emilia I ; Ninic, Martina; Vukmirovic, Sasa ; Gagic, Zarko ; Mandic-Kovacevic, Nebojsa; Tubic, Biljana; Djukanovic, Djordje; Grujic-Letic, Nevena N | Article | 22M22 |
| 2024 | Computer-aided Drug Discovery of Epigenetic Modulators in Dual-target Therapy of Multifactorial Diseases | Oljačić, Slavica ; Popović-Nikolić, Marija ; Filipić, Brankica ; Gagić, Žarko ; Nikolić, Katarina | Reviews | 22M22 |
| 2023 | Design of experiments and Derringer's desirability function in optimisation and validation of RP-HPLC method for the analysis of enrofloxacin and its impurities | Dokmanović, Jelena; Kasagić-Vujanović, Irena; Gagić, Žarko ; Nikolić, Katarina ; Čarapić, Marija; Agbaba, Danica | Article | 22M22 |
| 2020 | In silico Methods for Design of Kinase Inhibitors as Anticancer Drugs | Gagić, Žarko ; Ružić, Dušan ; Đoković, Nemanja ; Đikić, Teodora ; Nikolić, Katarina | Article | 21M21 |
| 2019 | Rational design of multi-target compounds with potential anticancer activity | Dobričić, Vladimir D. ; Olujić, Jelena; Nikolić, Katarina ; Vučićević, Jelica; Gagić, Žarko ; Filipić, Slavica ; Agbaba, Danica ; Čudina, Olivera | Conference Paper | Mp. category will be shown later |
| 2018 | Molecular modeling and analysis of the 3D pharmacophore structure of the selective PI3K-α inhibitors as antitumor agents | Jovanović, Milan ; Nikolić, Katarina ; Gagić, Žarko ; Agbaba, Danica | Article | 52M52 |
| 2018 | 3D molecular pharmacophore determination of PI3K-α kinase inhibitors | Gagić, Žarko ; Jovanović, Milan ; Agbaba, Danica ; Nikolić, Katarina | Conference Paper | Mp. category will be shown later |
| 2018 | Ispitivanje citotoksične aktivnosti aminokiselinskih estara vitamina E na ćelijama tumora dojke i pluća | Gagić Ž ; Srdić-Rajić; Nikolić, Katarina M. ; Agbaba D. | Conference Paper | Mp. category will be shown later |
| 2018 | Određivanje strukture farmakofore, dizajn, sinteza i ispitivanje antiproliferativne aktivnosti derivata alfa-tokoferola i gama-tokotrienola | Gagić, Žarko P. | Doctoral theses | 70M70 |
| 2017 | QSAR modeling and structure based virtual screening of new PI3K/mTOR inhibitors as potential anticancer agents | Oluić, Jelena; Nikolić, Katarina ; Vučićević, Jelica; Gagić, Žarko ; Filipić, Slavica ; Agbaba, Danica | Conference Paper | Mp. category will be shown later |
| 2017 | 3D-QSAR, Virtual Screening, Docking and Design of Dual PI3K/mTOR Inhibitors with Enhanced Antiproliferative Activity | Oluić, Jelena; Nikolić, Katarina ; Vučićević, Jelica ; Gagić, Žarko ; Filipić, Slavica ; Agbaba, Danica | Article | 22M22 |
| 2016 | Synthesis of the vitamin E amino acid esters with an enhanced anticancer activity and in silico screening for new antineoplastic drugs | Gagić, Žarko ; Ivković, Branka ; Srdić-Rajić, Tatjana ; Vučićević, Jelica ; Nikolić, Katarina ; Agbaba, Danica | Article | 21M21 |
| 2016 | QSAR studies and design of new analogs of vitamin E with enhanced antiproliferative activity on MCF-7 breast cancer cells | Gagić, Žarko ; Nikolić, Katarina ; Ivković, Branka ; Filipić, Slavica ; Agbaba, Danica | Article | 21aM21a |
| 2014 | Application of thin layer and column chromatography in monitoring the synthesis of α- tocopheryl-lysine ester | Gagić, Žarko ; Ivković, Branka ; Nikolić, Katarina ; Agbaba, Danica | Article | 53M53 |